Uptake of third vaccine doses in people with inflammatory bowel disease
In this short correspondence published in The Lancet Gastroenterology and Hepatology, CITF-funded researchers Dr. Jessica Widdifield of the University of Toronto, Dr. Sasha Bernatsky of McGill University, and colleagues presented the frequency of SARS-CoV-2 vaccination in Ontario patients with inflammatory bowel disease (IBD).
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed